Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-084-8 | CAS number: 760-93-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- Ninth Addendum to OECD Guidelines for Testing of Chemicals, Section 4, No. 471, "Bacterial Reverse Mutation Test", adopted 21st July, 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- Commission Regulation (EC) No. 440/2008 B.13/14:"Mutagenicity - Reverse Mutation Test using Bacteria", dated May 30, 2008.
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Methacrylic anhydride
- EC Number:
- 212-084-8
- EC Name:
- Methacrylic anhydride
- Cas Number:
- 760-93-0
- Molecular formula:
- C8H10O3
- IUPAC Name:
- 2-methylprop-2-enoyl 2-methylprop-2-enoate
- Test material form:
- liquid
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 98
- Additional strain / cell type characteristics:
- other: his D 3052; rfa-; uvrB-; R-factor: frame shift mutations
- Species / strain / cell type:
- S. typhimurium TA 100
- Additional strain / cell type characteristics:
- other: his G 46; rfa-; UV1-B"; R-factor: base-pair substitutions
- Species / strain / cell type:
- S. typhimurium TA 1535
- Additional strain / cell type characteristics:
- other: his G 46; rfa-; UV1-B": base-pair substitutions
- Species / strain / cell type:
- S. typhimurium TA 1537
- Additional strain / cell type characteristics:
- other: his C 3076; rfa-; uvrB-: frame shift mutations
- Species / strain / cell type:
- S. typhimurium TA 102
- Additional strain / cell type characteristics:
- other: his G 428 (pAQI); rfa-; R-factor: base-pair substitutions
- Test concentrations with justification for top dose:
- The test item concentrations to be applied in the main experiments were chosen according to the results of the pre-experiment .
2.5 µL/plate was selected as the maximum concentration, The concentration range covered two logarithmic decades. Two independent experiments were performed with the following concentrations:
Experiment I:
0.00100,0.00316,0.0100,0.0316,0.100,0.316 and 1.0 µL/plate (TA 1535, TA 1537 and TA 102 without metabolic activation)
0.00316, 0.0100, 0.0316, 0.100, 0.316, 1.0 and 2.5 µL/plate
(with metabolic activation and TA 98, TA 100 without metabolic activation)
Experiment II:
0.00200, 0.00632, 0.0200, 0.0632, 0.200, 0.632 and 1.0 µL/plate
(without metabolic activation)
0.00632, 0.0200, 0.0632, 0.200, 0.632, 1.0 and 2.0 µL/plate
(with metabolic activation)
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine
- Remarks:
- without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- Preparation of Bacteria
SampIes of each tester strain were grown by culturing for 12 h at 38,5 °C in Nutrient Broth to the late exponential or early stationary phase of growth (approx, 10E+9 cells/mL),
The nutrient medium consists per litre:
8 g Nutrient Broth
5 g NaCI
A solution of 125 µL ampicillin (10 mg/mL) (TA 98, TA 100, TA 102) was added in order to retain the phenotypic characteristics of the strain,
Agar Plates
The Vogel-Bonner Medium E agar plates with 2% glucose used in the Ames Test were prepared by BSL BIOSERVICE GmbH or provided by an
appropriate supplier. Quality controls were performed.
Vogel-Bonner-salts contain per litre:
10 g MgS04x 7H2O
100 g citric acid
175 g NaNH4HP04 x 4 H2O
500 g K2HP04
Sterilisation was performed at 121°C in an autoclave.
Vogel-Bonner Medium E agar plates contain per litre:
15 g Agar Agar
20 mL Vogel-Bonner salts
50 mL glucose-solvent (40%)
Sterilisation was performed at 121°C in an autoclave.
Overlay Agar
The overlay agar contains per litre:
7.0 g Agar Agar
6.0 g NaCI
10.5 mg L-histidine x HCl x HzO
12.2 mg biotin
Sterilisation was performed at 121°C in an autoclave.
Mammalian Microsomal Fraction S9 Mix
The bacteria most commonly used in these reverse mutation assays do not possess the enzyme system which, in mammals, is known to convert
promutagens into active DNA damaging metabolites. In order to overcome this major drawback an exogenous
metabolic system was added in form of mammalian microsome enzyme activation mixture.
S9 Homogenate
The S9 liver microsomal fraction was preparcd at BSL BIO SERVICE GmbH. Male Wistar rats were induced with phenobarbital (80 mg/kg bw) and
ß-naphthoflavone (100 mg/kg bw) for three consecutive days by oral route.
The following quality control determinations are performed:
a) Biological activity in:
- the Salmonella typhimurium assay using 2-aminoanthracene
-the mouse lymphoma assay using benzol [ a ]pyrene
-the chromosome aberration assay using cyclophosphamide.
b) Sterility Test
A stock of the supernatant containing the microsomes was frozen in aliquots of 2 and 4.5 mL and stored at <-75 °C.
The protein concentration in the S9 preparation (Lot: 110310) was 31 mg/mL. The S9 mix preparation was performed according to Ames et al.
Preparation of S9 Mix
100 mM of ice-cold sodium-Ortho-phosphat-buffer, pH 7.4, was added to the following pre-weighed sterilised reagents to give final concentrations in the S9 mix of:
8 mM MgCl2; 33 mM KCI; 5 mM glucose-6-phosphate; 4 mM NADP
This solution was mixed with the liver 9000 x g supernatant fluid in the following proportion:
co-factor solution 9.5 parts
liver preparation 0.5 parts
During the experiment the S9 mix was stored on ice.
S9 Mix Substitution Buffer
The S9 mix substitution buffer was used in the study as a replacement of S9 mix,
without metabolic activation (-S9).
Phosphate-buffer (0.2 M) contains per litre:
0.2 M NaH2P04 x H20: 120 mL
0.2 M Na2HP04: 880 mL
The two solutions were mixed and the pH was adjusted to 7.4. Sterilisation was performed at 121°C in an autoclave.
This 0.2 M phosphate-buffer was mixed with 0.15 M KCI solution (sterile) in the following proportion:
0,2 M phosphate-buffer: 9.5 parts
0.15 M KCI solution: 0.5 parts
This S9 mix substitution buffer was stored at 4°C.
Experimental Performace
For the plate incorporation method the following materials were mixed in a test tube and poured over the surface of a minimal agar plate:
100 µL: Test solution at eaeh dose level, solvent control, negative control of reference mutagen solution (positive control),
500 µL: S9 mix (for testing with metabolic activation) or S9 mix substitution buffer (for testing without metabolic activation),
100 µL: Bacteria suspension (cf. Preparation of Baeteria, pre-culture of the strain),
2000 µL: Overlay agar
For each strain and dose level, including the controls, three plates were used,
After solidification the plates were inverted and incubated at 37°C for at least 48 h in the dark.
Data Recording
The colonies were counted using a ProtocoL counter (Meintrup DWS Laborgeräte GmbH). If precipitation of the test item precluded automatic
counting the revertant colonies were counted by hand, in addition, tester strains with a low spontaneous mutation frequency like TA 1535 and TA 1537 were counted manually, - Evaluation criteria:
- Cytotoxicity can be detected by a clearing or rather diminution of the background lawn
or a reduction in the number of revertants down to
a mutation factor of approximately <= 0.5 in relation to the solvent control
A test is considered acceptable if for each strain: the bacteria demonstrate their typical responses to ampicillin (TA 98, TA 100, TA 102) the control plates with and without S9 mix are within the following ranges (mean values of the spontaneous reversion frequency are within the historical control data
range):
- S9 +S9
TA 98: 18 18-46 18- 57
TA 100: 77 - 163 78 - 165
TA 1535: 5 -29 5-27
TA 1537: 5 -30 5 -36
TA 102: 164 -390 163 -472
- corresponding background growth on negative control, solvent control and test plates is observed
- the positive controls show a distinct enhancement of revertant rates over the control Plate
The Mutation Factor is calculated by dividing the mean value of the revertant counts
through the mean values of the solvent control
A test item is considered as mutagenic if:
a clear and dose-related increase in the number of revertants occurs and/or
- a biologically relevant positive response for at least one of the dose groups occurs in at least one tester strain with or without metabolic activation.
A biologically relevant increase is described as follows:
- if in tester strains TA 98, TA 100 and TA 102 the number of reversions is at least twice as high
- if in tester strains TA 1535 and TA 1537 the number of reversions is at least three times higher than the reversion rate of the solvent control.
Acc. to OECD guidelines, the biol. relevance of the results is the criterion for the interpretation of results, a statistical evaluation of the results is not regarded as necessary.
A test item producing neither a dose related increase in the number of revertants nor a reproducible biologically relevant positive response at any of the dose groups is considered to be non-mutagenic in this system. - Statistics:
- According to OECD guidelines, the biological relevance of the results is the criterion for the interpretation of results, a statistical evaluation of the results is not regarded as necessary.
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- It can be stated that during the described mutagenicity test and under the experimental conditions reported, Methacrylic anhydride did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used.
Therefore, Methacrylic anhydride is considered to be non-mutagenic in this bacterial reverse mutation assay. - Executive summary:
In a reverse gene mutation assay in bacteria (Ames test), strains TA1535, TA1537, TA98, TA100, and TA102 of Salmonella typhimuriumwere exposed to Methacrylic anhydride at concentrations of up to 2.0 µl/plate in the presence and absence of mammalian metabolic activation S9 -mix.
No biologically relevant inereases in revertant colony numbers of any of the five tester strains were observed following treatment with Methacrylic anhydride at any concentration level, neither in the presence nor absence of metabolic activation in experiment I and II
The reference mutagens induced a distinct increase of revertant colonies indicating the validity of the experiments.
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, Methacrylic anhydride did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used.
Therefore, Methacrylic anhydride is considered to be non-mutagenic in this bacterial reverse mutation assay. Appropriate reference mutagens were used as positive controls.
The positive controls induced the appropriate responses in the corresponding strains.
This study is classified as acceptable. This study satisfies the requirement for tests for in vitro mutagenicity (bacterial reverse gene mutation) data.
This study is classified as acceptable, it satisfies the requirements for testing bacterial reverse mutations.
NOTE: Any of data in this dataset are disseminated by the European Union on a right-to-know basis and this is not a publication in the same sense as a book or an article in a journal. The right of ownership in any part of this information is reserved by the data owner(s). The use of this information for any other, e.g. commercial purpose is strictly reserved to the data owners and those persons or legal entities having paid the respective access fee for the intended purpose.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.